MeSH term
Frequency | Condition_Probility | Acute Disease | 3 | 0.0 |
*Neoplasm Proteins | 3 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
*Proto-Oncogenes | 7 | 1.0 |
*Transcription Factors | 4 | 0.0 |
Adult | 6 | 0.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Humans | 15 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Karyotyping | 5 | 0.0 |
Male | 6 | 0.0 |
*Proto-Oncogene Proteins | 7 | 0.0 |
Transcription Factors/*genetics | 5 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Chromosomes, Human, Pair 3/*genetics | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
Animals | 4 | 0.0 |
Cell Line | 2 | 0.0 |
Mice | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Transfection | 3 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Leukemia, Myeloid/*genetics | 3 | 2.0 |
Molecular Sequence Data | 4 | 0.0 |
Translocation, Genetic | 4 | 0.0 |
Child | 3 | 0.0 |
Fatal Outcome | 2 | 0.0 |
Female | 4 | 0.0 |
Middle Aged | 3 | 0.0 |
*Translocation, Genetic | 6 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Gene Expression Regulation, Leukemic | 2 | 2.0 |
Prognosis | 3 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 21 | 2 | 1.0 |
*Chromosomes, Human, Pair 3 | 4 | 1.0 |
Comparative Study | 3 | 0.0 |
*Gene Rearrangement | 2 | 0.0 |
Rats | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Transcription Factors/biosynthesis/*genetics | 2 | 1.0 |
*Repressor Proteins | 2 | 0.0 |
Aged | 2 | 0.0 |
Base Sequence | 2 | 0.0 |
*Oncogene Proteins, Fusion | 2 | 7.0 |
RNA Splicing | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Neoplasm Proteins/*genetics | 3 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
RNA-Binding Proteins/genetics | 2 | 3.0 |
*Ribosomal Proteins | 2 | 8.0 |
Chromosomes, Human, Pair 3 | 2 | 1.0 |
